What's new? Log in Free sign up

DICE Therapeutics (DICE)

Company Profile

Company profile

Ticker

DICE

Exchange

Website

www.dicetherapeutics.com

Incorporated

Location

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris • AbbVie • Bausch Health Companies ...

Former names

DiCE Molecules Holdings, LLC, DiCE MOLECULES HOLDINGS, LLC

SEC CIK

Corporate docs

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

DiCE Molecules SV, Inc. • DiCE Alpha, Inc. ...

IRS number

472286244

DICE stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Securities registration termination

Notice of effectiveness

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Registration of securities for employees (post-effective amendment)

Automatic shelf registration (post-effective amendment)

Prospectus update (post-effective amendment)

Termination of a Material Definitive Agreement

Tender offer solicitation (amended)

Third party tender offer statement (amended)

Latest ownership filings

View all

RA CAPITAL MANAGEMENT, L.P.

James Paul Scopa

Scott M. Robertson

RICHARD H SCHELLER

John R. Jacobsen

Financial summary

Financial statements Chart DICE financial data

Quarter (USD)	Jun 23	Mar 23	Dec 22	Sep 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	73.66 mm	73.66 mm	73.66 mm	73.66 mm	73.66 mm	73.66 mm
Cash burn (monthly)	9.38 mm	(no burn)	13.17 mm	9.89 mm	9.53 mm	7.02 mm
Cash used (since last report)	188.13 mm	n/a	264.15 mm	198.44 mm	191.11 mm	140.82 mm
Cash remaining	-114.46 mm	n/a	-190.48 mm	-124.78 mm	-117.45 mm	-67.16 mm
Runway (months of cash)	-12.2	n/a	-14.5	-12.6	-12.3	-9.6

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

DICE institutional ownership history Ownership history

2.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2	2	–
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	57.25 mm	57.25 mm	–
Total shares	1.23 mm	1.23 mm	–
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Northpond Ventures	633.71 k	$29.54 mm	0.0%
Sands Capital Life Sciences Pulse Fund II	596.69 k	$27.71 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Northpond Ventures	633.71 k	0.00	0.0%
Sands Capital Life Sciences Pulse Fund II	596.69 k	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.